日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prediction of Metabolic Parameters of Diabetic Patients Depending on Body Weight Variation Using Machine Learning Techniques

利用机器学习技术预测糖尿病患者体重变化相关的代谢参数

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines13051116
Vîrgolici, Oana; Lixandru, Daniela; Mihai, Andrada; Ștefan, Diana Simona; Guja, Cristian; Vîrgolici, Horia; Virgolici, Bogdana
糖尿病
代谢
发表日期：2025
文献求助 收藏

Interactions between Gut Microbiota and Oral Antihyperglycemic Drugs: A Systematic Review

肠道菌群与口服降血糖药物的相互作用：系统评价

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms25063540
Mindrescu, Nicoleta Mihaela; Guja, Cristian; Jinga, Viorel; Ispas, Sorina; Curici, Antoanela; Nelson Twakor, Andreea; Pantea Stoian, Anca Mihaela
微生物学
肠道菌群
发表日期：2024
文献求助 收藏

Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel

来自东南欧地区和以色列的专家对当前胰岛素在2型糖尿病患者管理中的应用趋势的看法

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-024-01556-z
Tabak, Adam G; Kempler, Peter; Guja, Cristian; Eldor, Roy; Haluzik, Martin; Klupa, Tomasz; Papanas, Nikolaos; Stoian, Anca Pantea; Mankovsky, Boris
代谢
糖尿病
免疫/内分泌
发表日期：2024
文献求助 收藏

Real-Life Effectiveness of iGlarLixi (Insulin Glargine 100 U/ml and Lixisenatide) in People with Type 2 Diabetes (T2D) According to Baseline HbA1c and BMI

根据基线糖化血红蛋白 (HbA1c) 和体重指数 (BMI) 评估 iGlarLixi（甘精胰岛素 100 U/ml 和利西拉肽）在 2 型糖尿病 (T2D) 患者中的真实世界疗效

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-024-01644-0
Kis, Janos T; Seufert, Jochen; Haluzík, Martin; Bonnemaire, Mireille; Vera, Carine; Tournay, Mathilde; Freemantle, Nick; Guja, Cristian
代谢
糖尿病
免疫/内分泌
发表日期：2024
文献求助 收藏

Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group

现代心血管代谢连续谱管理：从超重/肥胖到糖尿病前期/2型糖尿病。东欧和南欧糖尿病与肥胖专家组的建议

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-024-01615-5
Janez, Andrej; Muzurovic, Emir; Bogdanski, Pawel; Czupryniak, Leszek; Fabryova, Lubomira; Fras, Zlatko; Guja, Cristian; Haluzik, Martin; Kempler, Peter; Lalic, Nebojsa; Mullerova, Dana; Stoian, Anca Pantea; Papanas, Nikolaos; Rahelic, Dario; Silva-Nunes, José; Tankova, Tsvetalina; Yumuk, Volkan; Rizzo, Manfredi
糖尿病
肥胖
代谢
发表日期：2024
文献求助 收藏

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.

糖尿病血脂异常中的微囊泡相关和循环微RNA：miR-218、miR-132、miR-143、miR-21、miR-122、miR-155 具有生物标志物潜力

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-023-01988-0
Nemecz Miruna, Stefan Diana Simona, Comarița Ioana Karla, Constantin Alina, Tanko Gabriela, Guja Cristian, Georgescu Adriana
代谢
糖尿病
囊泡
发表日期：2023
文献求助 收藏

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis

根据每日给药时间评估 iGlarLixi（甘精胰岛素 100 U/mL 加利西拉肽）治疗 2 型糖尿病的有效性和安全性：来自 REALI 汇总分析的数据

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-023-01375-8
Haluzík, Martin; Seufert, Jochen; Guja, Cristian; Bonnemaire, Mireille; Bigot, Gregory; Tournay, Mathilde; Kis, János Tibor; Freemantle, Nick
代谢
糖尿病
免疫/内分泌
发表日期：2023
文献求助 收藏

Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results

成人2型糖尿病患者同时接受iGlarLixi和钠-葡萄糖协同转运蛋白2抑制剂治疗：LixiLan-G试验和真实世界证据结果

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-021-01180-1
Guja, Cristian; Giorgino, Francesco; Blonde, Lawrence; Ali, Amar; Prázný, Martin; Meier, Juris J; Souhami, Elisabeth; Lubwama, Robert; Ji, Chen; Rosenstock, Julio
糖尿病
代谢
发表日期：2022
文献求助 收藏

Subclinical hypothyroidism has no association with insulin resistance indices in adult females: A case-control study

亚临床甲状腺功能减退症与成年女性胰岛素抵抗指标无相关性：一项病例对照研究

期刊:
影响因子:
doi:10.3892/etm.2021.10465
Stoica, Roxana Adriana; Ancuceanu, Robert; Costache, Adrian; Ștefan, Simona Diana; Stoian, Anca Pantea; Guja, Cristian; Ștefan-van Staden, Raluca Ioana; Popa-Tudor, Ioana; Serafinceanu, Cristian; Ionescu-Tîrgoviște, Constantin
代谢
甲状腺功能减退
免疫/内分泌
发表日期：2021
文献求助 收藏

Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting-the GOAL_RO trial

在真实世界环境下，胰岛素格列净 Gla-300 对未接受过胰岛素治疗的 2 型糖尿病患者的有效性和安全性——GOAL_RO 试验

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-20-4533
Stegaru, Daniela; Nicodim, Simona; Vladu, Delia; Guțu, Olimpia; Onaca, Adriana; Pîrvu, Florina; Moise, Mihaela; Guja, Cristian
代谢
糖尿病
免疫/内分泌
发表日期：2021
文献求助 收藏